Upon encountering antigen in the context of antigen presenting cells, naïve CD4 + T cells undergo differentiation into effector T helper (Th) cells, which can secrete high levels of cytokines and other immunomodulators to mediate host defense and tissue inflammation. During the past three years, the immunology field has witnessed an explosion of research advances in the biology of Th17 cells, the most recently described subset of T helper cells, which play critical roles in host immunity and inflammation. Here we review emerging data on transcriptional regulatory networks that govern the differentiation program of Th17 cells, and focus on how the orphan nuclear receptor RORγt coordinates this process in concert with diverse cytokine-induced transcription factors.
Introduction
The T helper cell (Th) paradigm, introduced by Mosmann and Coffman more than two decades ago, has been used to explain how different adaptive immune responses are elicited in the host organism for the purpose of eradicating infections with diverse microbial pathogens [1] . Th1 and Th2 cells, described in the original studies, have now been joined by Th17 cells that make the signature cytokines IL-17, IL-17F and IL-22 [2••,3•, 4 •]. These cells are involved in clearance of extracellular pathogens, particularly at mucosal surfaces [5•,6,7] , where IL-17 induces recruitment and differentiation of neutrophils and IL-22 is required for production of anti-microbial defensins.
Excessive or persistent effector T cell responses can drive the onset of inflammatory diseases. It is now clear that Th17 cells, along with Th1 cells, are often responsible for autoimmune disease, and may also contribute to tumor progression due to the role of their cytokines in inflammation and tissue repair [8] . Another subset of CD4 + T cells, the regulatory T cells (Tregs), suppress effector T cell responses and prevent their potentially pathogenic effects [9] . There are two major categories of Foxp3 + Tregs, the naturally occurring CD4 + CD25 + Tregs (nTregs) that arise in the thymus and the TGF-β-induced Tregs (iTregs) produced in the periphery. Both types of Tregs are likely to be important in maintaining peripheral tolerance and preventing autoimmunity, but their individual contributions have not yet been established in vivo [10] . The T helper cell differentiation program is largely controlled by cytokines produced in response to microbial products by innate immune cells. These include IL-12/ IFNγ for Th1 differentiation, IL-4 for Th2 differentiation, and IL-23 which has been linked to pathogenesis ascribed to Th17 cells both in mice and humans [11] . However, differentiation of IL-17-producing murine T helper cells in vitro does not require IL-23, but is dependent instead on a unique cytokine combination, IL-6 plus TGF-β [5•,12••,13••]. Differentiation of human Th17 cells was initially thought to be independent of TGF-β, but has recently been shown to also require this cytokine [14] [15] [16] .
The differentiation of each effector T cell subset requires the induction and/or function of a series of transcriptional regulators that interact with each other in complex networks and thus orchestrate the functional program of the cells. For each T helper cell differentiation program, single transcription factors have been identified as pivotal regulators, named by some "master regulators" because their overexpression can induce transcription of the relevant cytokine genes, presumably by directly binding to their cis-regulatory elements. These transcription factors include T-bet for Th1 cells and GATA3 for Th2 cells [17] . Foxp3 was identified as a specific regulator for Tregs and controls the expression of multiple genes that mediate Treg cell functions [18, 19] . Retinoid-related orphan receptor (ROR)γt, but not T-bet or GATA3, was identified as a Th17-specific transcription factor, further demonstrating that Th17 cells have an unique T effector program [20••] . However, RORγt does not function in isolation, but coordinates the activity of a series of other essential transcription factors in guiding the differentiation of Th17 cells. The roles of RORγt in the context of other transcriptional regulators will be discussed in this review.
Unique cytokine environment for Th17 cell differentiation
Th17 cells were discovered after IL-23-deficient mice (lacking expression of the p19 polypeptide unique to this cytokine) were found to be resistant to multiple models of autoimmune disease and also to have markedly reduced expression of IL-17 by their activated T helper cells. It has been proposed that IL-23 is required for Th17 cell function in vivo through control of their expansion and/or maintenance, but this has not been demonstrated in experimental models [21, 22] . Moreover, recent reports have indicated that the frequency of IL-17 + T helper cells in the intestine at steady state or after infection with Citrobacter rodentium was not affected by the absence of IL-23 [5•,23] . However, there is compelling evidence that production of IL-22 by T helper cells is dependent on IL-23 and survival of animals after C. rodentium infection requires both IL-23 and IL-22 [5•,6] . Therefore, it will be important to evaluate the roles of both IL-17 and IL-22 in autoimmune diseases dependent on IL-23. It is also possible that IL-23 influences other effector functions that are critical to inflammatory diseases mediated by T helper cells [24] . Thus, the precise mechanisms underlying the contribution of IL-23 to Th17 cell differentiation and function in vivo remain to be elucidated. It was recently shown that mice deficient for gp130 (a shared receptor subunit for IL-6) mounted efficient Th17 responses and developed experimental autoimmune encephalomyelitis (EAE) after depletion of Treg cells, suggesting that IL-6 signaling was dispensable for the induction of pathogenic Th17 cells in vivo, at least in the absence of Treg cells [32] . These results highlight the complexity of the cytokine-induced Th17 differentiation program, suggesting that in vivo Th17 cell differentiation can be driven by multiple proinflammatory cytokines (IL-6, IL-21, IL-23 and/or other yet unidentified factors).
TGF-β has been extensively characterized as being required to maintain immunological tolerance, acting in both differentiation and maintenance of Foxp3 + Tregs that restrain effector T cell responses [33] . Why TGF-β is required for both proinflammatory Th17 cell and antiinflammatory Treg differentiation remains paradoxical. Most recently, we showed that TGF-β orchestrates in vitro Th17 and Treg cell differentiation programs in a concentrationdependent manner ( In spite of the absolute requirement of TGF-β, little is known about its precise signaling pathways in Th17 and Treg cell differentiation. Since Smad4 (a co-smad in the Smad-dependent TGF-β pathway) appears not to be required for Th17 cell differentiation [34] , the involvement of Smaddependent or -independent pathways in Th17 and Treg cell differentiation needs to be carefully examined. It will be important to determine if modulation of active TGF-β concentration or sensitivity to TGF-β in vivo results in differential loss of Treg versus Th17 cells. On this basis, polymorphisms in TGF-β signaling pathway genes may also contribute to human autoimmune diseases.
Th17 transcriptional regulatory networks
Th17 cell lineage specification requires RORγt, which was earlier identified as a critical transcription factor for early T cell and lymphoid organ development [35] [36] [37] . IRF-4, a transcription factor previously shown to be important for Th2 cell differentiation, was also discovered to be essential for Th17 cell differentiation. IRF4-deficient mice were protected from EAE and T cells from these animals failed to differentiate into Since rescue was only partial, it is likely that a complex transcriptional network, rather than a linear process, governs the Th17 cell differentiation program. Furthermore, IRF4-deficient T cells had increased Foxp3 expression, highlighting the importance of the RORγt-Foxp3 balance in Th17/Treg cell differentiation. Th17 cells have also been shown to express c-Maf, a transcription factor involved in regulation of Th2 cell differentiation. Genetic loss of c-Maf resulted in a defect in IL-21 production, IL-23R expression, and, consequently, in fewer Th17 cells [51] .
The discovery of the involvement of aryl hydrocarbon receptor (AhR) in the regulation of transcription of Th17 cytokines has added another layer of complexity to this field [52••, 53••]. AhR, a mediator of the effects of environmental toxins (e.g. dioxin, a polycyclic aromatic hydrocarbon xenobiotic compound), is a ligand-dependent transcription factor that is structurally distinct from the nuclear receptor superfamily. Upon binding to a ligand (such as dioxin or FICZ, a UV photoproduct of tryptophan), cytosolic AhR translocates into the nucleus, heterodimerizes with its partner aryl hydrocarbon receptor nuclear translocator (ARNT), and turns on transcription of its target genes [54] . The findings of the involvement of AhR in Th17 cell differentiation suggest a potential link between environmental pollution and inflammation. However, the precise contribution of AhR to Th17 cell differentiation is unclear. Analysis of AhR-deficient cells has shown that it is required for IL- 22 
In vivo relevance and implications
The local cytokine environment greatly influences immune system homeostasis through regulation of various transcription factors. Local TGF-β concentration, together with proinflammatory cytokines, may determine the balance between Foxp3 and RORγt (and probably other Th17 transcription factors as well), leading to different T cell fates. This is especially relevant in the gut environment where, upon encountering commensal bacteria, dendritic cells secrete proinflammatory cytokines. High concentrations of TGF-β, together with retinoic acid (RA), may be required for induction of Foxp3 + Tregs to suppress potentially detrimental inflammatory Th17 cell responses [57] [58] [59] [60] [61] [62] . The inhibition of IL-6 receptor (IL-6Rα) expression by RA, suggested by a recent study, provides at least in part an explanation for how RA antagonizes Th17 cell differentiation [63] . Foxp3 inhibits RORγt-directed IL-17 expression in mouse T cells, but it remains to be determined whether this also occurs in humans. This is relevant because FOXP3ΔExon2 is a natural spliced isoform that was only identified in humans. Thus, the balance between full-length FOXP3 versus FOXP3ΔExon2 may influence the frequency of Th17 and Treg cells and susceptibility to autoimmunity in humans. Modulation of the interaction between RORγt (together with other Th17 transcription factors) and Foxp3 may thus maintain immune homeostasis and permit control of inflammatory responses in different disease settings.
Conclusions
Over the past three years, there have been remarkable advances in our understanding of Th17 cell differentiation and function. Transcriptional regulatory networks that specify Th17 differentiation program have begun to be elucidated, but our understanding is likely still superficial (Figure 2) . Little is known about precise molecular mechanisms whereby these interactions determine the Th17 differentiation program. Furthermore, aside from several effector cytokine genes, the targets of these transcriptional regulators in the Th17 program are unclear. In addition, the mechanism by which RORγt is regulated by a yet unknown ligand remains to be characterized. RORγt function and its interaction with Foxp3 may be manipulated pharmacologically using small molecule compounds. Our knowledge of the interplay among different T helper cell lineages at the molecular level will shed light on human disease pathogenesis and may eventually provide novel means for treating inflammatory and autoimmune diseases. The inflammatory cytokine (IL-6)-initiated signaling cascade, together with TGF-β signaling, induces RORγt expression in a Stat3-dependent manner. In the absence of proinflammatory cytokines, TGF-β-induced Foxp3 inhibits RORγt (and RORα) activity, and thus promotes Treg cell differentiation. AhR is also induced during Th17 cell polarization and it downregulates Foxp3 expression. Ligand activated AhR cooperates with RORγt to induce maximal amounts of IL-17 and IL-22 and also to inhibit TGF-β-induced Foxp3 expression, ensuring full progression of Th17 cell differentiation. TCR-induced IRF-4 upregulates RORγt expression and inhibits Foxp3 expression, and thus promotes Th17 cell differentiation and antagonizes Treg cell differentiation. TCR-activated IBP inhibits IRF-4 function by sequestering IRF-4. TCR-induced Runx1 influences Th17 cell differentiation by inducing RORγt expression and by binding to and acting together with RORγt to direct il17 transcription.
